Free Trial

ECO Animal Health Group (EAH) Competitors

ECO Animal Health Group logo
GBX 93.89 +1.39 (+1.50%)
As of 11:41 AM Eastern

EAH vs. BXP, ANCR, STX, VLG, DNL, PXS, MXC, RGT, CEL, and CHLL

Should you be buying ECO Animal Health Group stock or one of its competitors? The main competitors of ECO Animal Health Group include Beximco Pharmaceuticals (BXP), Animalcare Group (ANCR), Shield Therapeutics (STX), Venture Life Group (VLG), Diurnal Group (DNL), Provexis (PXS), Argent BioPharma (MXC), Argent BioPharma (RGT), Celadon Pharmaceuticals (CEL), and Chill Brands Group (CHLL). These companies are all part of the "drug manufacturers - specialty & generic" industry.

ECO Animal Health Group vs. Its Competitors

Beximco Pharmaceuticals (LON:BXP) and ECO Animal Health Group (LON:EAH) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, analyst recommendations, earnings, valuation, institutional ownership, dividends, media sentiment and profitability.

In the previous week, Beximco Pharmaceuticals' average media sentiment score of 0.00 equaled ECO Animal Health Group'saverage media sentiment score.

Company Overall Sentiment
Beximco Pharmaceuticals Neutral
ECO Animal Health Group Neutral

Beximco Pharmaceuticals has a net margin of 13.71% compared to ECO Animal Health Group's net margin of 1.17%. Beximco Pharmaceuticals' return on equity of 13.12% beat ECO Animal Health Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Beximco Pharmaceuticals13.71% 13.12% 6.97%
ECO Animal Health Group 1.17%1.27%2.14%

1.2% of Beximco Pharmaceuticals shares are held by institutional investors. Comparatively, 46.3% of ECO Animal Health Group shares are held by institutional investors. 4.2% of Beximco Pharmaceuticals shares are held by insiders. Comparatively, 11.0% of ECO Animal Health Group shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Beximco Pharmaceuticals has higher revenue and earnings than ECO Animal Health Group. Beximco Pharmaceuticals is trading at a lower price-to-earnings ratio than ECO Animal Health Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Beximco Pharmaceuticals£46.34B0.00£970.84B£14.253.08
ECO Animal Health Group£79.60M0.80£1.05M£0.023,863.79

Beximco Pharmaceuticals has a beta of 0.61, indicating that its share price is 39% less volatile than the S&P 500. Comparatively, ECO Animal Health Group has a beta of -0.05, indicating that its share price is 105% less volatile than the S&P 500.

ECO Animal Health Group has a consensus price target of GBX 150, indicating a potential upside of 59.76%. Given ECO Animal Health Group's stronger consensus rating and higher possible upside, analysts clearly believe ECO Animal Health Group is more favorable than Beximco Pharmaceuticals.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Beximco Pharmaceuticals
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
ECO Animal Health Group
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Summary

Beximco Pharmaceuticals and ECO Animal Health Group tied by winning 7 of the 14 factors compared between the two stocks.

Get ECO Animal Health Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for EAH and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding EAH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

EAH vs. The Competition

MetricECO Animal Health GroupDrug Manufacturers IndustryMedical SectorLON Exchange
Market Cap£63.37M£1.72B£6.02B£2.59B
Dividend Yield0.94%2.95%5.66%5.28%
P/E Ratio3,863.79116.3085.364,388.08
Price / Sales0.801,585.94583.50100,187.79
Price / Cash6.0510.3738.3227.90
Price / Book0.6811.4712.738.71
Net Income£1.05M£20.70B£3.30B£5.89B
7 Day Performance-0.49%-0.63%1.04%-0.06%
1 Month Performance27.74%2.78%7.62%2.40%
1 Year Performance34.28%9.17%79.71%145.49%

ECO Animal Health Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
EAH
ECO Animal Health Group
N/AGBX 93.89
+1.5%
GBX 150
+59.8%
+31.6%£63.37M£79.60M3,863.79234
BXP
Beximco Pharmaceuticals
N/AGBX 43.06
-2.1%
N/A+65.6%£192.10M£46.34B3.025,500Gap Down
ANCR
Animalcare Group
N/AGBX 226
-1.7%
N/A-4.4%£155.92M£81.07M6,277.78220
STX
Shield Therapeutics
1.5578 of 5 stars
GBX 8.03
-2.7%
GBX 15
+86.8%
+100.8%£85.26M£41.50M-401.5040,000Gap Down
VLG
Venture Life Group
N/AGBX 53.15
-0.7%
N/A+15.5%£68.06M£31.23M-6,993.55165Positive News
DNL
Diurnal Group
N/AN/AN/AN/A£46.33M£4.68M-3.2133
PXS
Provexis
N/AGBX 0.62
flat
N/AN/A£14.49M£1.20M-2,058.334
MXC
Argent BioPharma
N/AN/AN/AN/A£9.65M£1.32M-13.255Gap Up
RGT
Argent BioPharma
N/AN/AN/AN/A£8.31MN/A-0.65N/AGap Down
High Trading Volume
CEL
Celadon Pharmaceuticals
N/AGBX 13.40
flat
N/AN/A£8.22M£123.38K-1.682,780
CHLL
Chill Brands Group
N/AGBX 1.35
-3.6%
N/AN/A£7.06M£305.70K-207.697Gap Down

Related Companies and Tools


This page (LON:EAH) was last updated on 10/10/2025 by MarketBeat.com Staff
From Our Partners